These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Felbamate in the treatment of acquired epileptic aphasia. Glauser TA; Olberding LS; Titanic MK; Piccirillo DM Epilepsy Res; 1995 Jan; 20(1):85-9. PubMed ID: 7713063 [TBL] [Abstract][Full Text] [Related]
63. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Kohl BK; Dannhardt G Curr Med Chem; 2001 Sep; 8(11):1275-89. PubMed ID: 11562266 [TBL] [Abstract][Full Text] [Related]
64. From the Food and Drug Administration. Nightingale SL JAMA; 1993 Oct; 270(14):1672. PubMed ID: 8411485 [No Abstract] [Full Text] [Related]
65. Effect of felbamate on phenytoin and carbamazepine serum concentrations. Graves NM; Holmes GB; Fuerst RH; Leppik IE Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472 [TBL] [Abstract][Full Text] [Related]
66. The new antiepileptic drugs. Appleton RE Arch Dis Child; 1996 Sep; 75(3):256-62. PubMed ID: 8976672 [No Abstract] [Full Text] [Related]
67. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate. Smith RD; Grzelak ME; Coffin VL Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055 [TBL] [Abstract][Full Text] [Related]
68. Felbamate: consensus of current clinical experience. Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941 [TBL] [Abstract][Full Text] [Related]
69. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1. Kieć-Kononowicz K; Karolak-Wojciechowska J; Handzlik J Acta Pol Pharm; 1998; 55(5):381-8. PubMed ID: 9921116 [TBL] [Abstract][Full Text] [Related]
72. Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changes. Longo R; Domenici MR; Scotti de Carolis A; Sagratella S Life Sci; 1995; 56(21):PL409-14. PubMed ID: 7537844 [TBL] [Abstract][Full Text] [Related]
73. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice. Swiader M; Gasior M; Wielosz M; Czuczwar SJ Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726 [TBL] [Abstract][Full Text] [Related]
74. Autoradiography and interaction of modulators of NMDA receptor activation. Bowery NG; Fletcher AE; Price GW; Ransom R; Wilkin GP; Wong EH Epilepsy Res Suppl; 1992; 8():189-96. PubMed ID: 1329813 [No Abstract] [Full Text] [Related]
75. Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats. Borowicz KK; Ratnaraj N; Patsalos PN; Czuczwar SJ Pharmacol Biochem Behav; 2004 May; 78(1):103-10. PubMed ID: 15159139 [TBL] [Abstract][Full Text] [Related]
76. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190 [TBL] [Abstract][Full Text] [Related]
77. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice. De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966 [TBL] [Abstract][Full Text] [Related]
79. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients. Luer MS Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896 [No Abstract] [Full Text] [Related]
80. Efficacy and safety of felbamate in children with refractory epilepsy. Heyman E; Levin N; Lahat E; Epstein O; Gandelman-Marton R Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]